Langen / San Francisco / Garsfontein / Tehran / Osaka / Nonthaburi / Hyderabad / Ottawa / Tokyo / Pune / Chungcheongbuk-do / Wavre / Amsterdam / Bilthoven / Jakarta / Buenos Aires / Geneva / Nyon / Brasilia / Strasbourg / Rockville / Giza / Kingston / Cambridge / Beijing / Copenhagen / Lokeren / Lille / Brussels / /
Company
USA (Rapporteur) Dr L.S. Slamet / Biological E. Limited / GlaxoSmithKline Biologicals / 2 National Agency of Drug / Amgen Inc. / Food Control / /
Country
Switzerland / Netherlands / Colombia / Canada / United Kingdom / China / Germany / Iran / Belgium / United States / Argentina / / /
Facility
Research Dr J.P. Weir / Serum Institute of India / National Institute / University of Texas Medical Branch / Potters Bar / East Anglia Blood Centre / National Institute of Infectious Diseases / Statens Serum Institute / / /
IndustryTerm
active pharmaceutical ingredient / blood products / plasma-derived medicinal products / equitable health systems / /
MedicalCondition
diphtheria / influenza H1N1pdm / human diphtheria / control disease / recombinant malaria / tetanus / disease / Japanese encephalitis / poliomyelitis / acellular pertussis / /
MedicalTreatment
Immunization / antibiotics / /
Organization
Combination Vaccines Division / University of Texas Medical Branch / World Health Organization / Biologic Department / USA International Federation of Clinical Chemistry / Indonesia Dr Y. Sohn / Korea Food & Drug Administration / Dr L.S. Slamet / 2 National Agency of Drug and Food Control / USA Pharmaceutical and Medical Device Regulatory Science Society of Japan / the Netherlands International Society on Thrombosis / Biological Standardization Council of Europe / Centre for Vaccine Evaluation / Statens Serum Institute / USA Chinese Pharmacopoeia Commission / Food and Drug Organization / France International Alliance of Biological Standardization Dr W. Egan / Paul-Ehrlich-Institut / Biologic and Genetic Therapies Directorate / Serum Institute of India / Pharmaceutical & Narcotic Affairs Division / USA International Plasma Fractionation Association / National Institute of Infectious Diseases / Centre for Blood and Tissues Evaluation / South African National Blood Service / Ministry of Health / European Directorate for the Quality of Medicines / National Administration of Drugs / Food and Medical Technology / WHO Immunization Practices Advisory Committee / WHO Secretariat / Food and Drug Administration / India Institut / National Institute for Public Health and the Environment / England Dr J. Fryer / 3 National Institute / National Institute for Biological Standards and Control / Division of Biological Products / American Red Cross / Alliance of Blood Operators Dr G. Sher / East Anglia Blood Centre / France International Federation of Pharmaceutical Manufacturers / National Blood Transfusion Service / United Nations / Society of Japanese Pharmacopoeia / Center for Biologics Evaluation and Research / American Association of Blood Banks / the Netherlands Plasma Protein Therapeutics Association / Ministry of Public Health / /
Person
R. J. Benjamin / G. Sher / D. Schmalzing / C. Conrad / S. Fakhrzadeh / P. Aprea / E. Griffiths / J. Petricciani / L. Castanheira / P. Vandoolaeghe / P. Gillery / S. Gairola / P.V.V.S. Murthy / M. Baca-Estrada / Bethesda / H. Klein / I. Hamaguchi / C. Saillez / E. Charton / T.S. Morris / K. Cichutek / R. Perry / M. Bhalgat / M. Heiden / P. Strengers / G. Zhongpin / T. Jivapaisarnpong / K. Mertens / A. Barrett / K.H. Buchheit / T. Burnouf / T. Murai / P. Lenting / M. Gustafson / A. Mire-Sluis / K. Shoos / S. Pagliusi / R. Dobbelaer / / /
980 W H O Te c h n i c a l